Shire’s drug Vyvanse became the first drug approved for sale in the U.S. to treat the estimated 2.8 million adults who have a binge-eating disorder.
from WSJ.com: US Business http://ift.tt/1zgv9SD
via IFTTT
from WSJ.com: US Business http://ift.tt/1zgv9SD
via IFTTT
No comments:
Post a Comment